ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
60 hedge funds and large institutions have $9.86M invested in Acorda Therapeutics in 2020 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 28 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
87% less call options, than puts
Call options by funds: $103K | Put options by funds: $793K
Holders
60
Holding in Top 10
–
Calls
$103K
Puts
$793K
Top Buyers
| 1 | +$733K | |
| 2 | +$384K | |
| 3 | +$318K | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$65.8K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$59.5K |
Top Sellers
| 1 | -$757K | |
| 2 | -$706K | |
| 3 | -$590K | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$464K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$416K |